Hugo Hämmerle
Gründer bei Tissue Engineering Technologies AG
Profil
Hugo Hämmerle is the founder of Tissue Engineering Technologies AG.
He currently holds the position of Deputy Chairman-Supervisory Board at Retina Implant AG, Director-Natural & Medical Science Institute at Eberhard Karls Universität Tübingen since 2012, and Managing Director at NMI Technologietransfer GmbH.
Previously, he served as a Member-Supervisory Board at STRATEC SE from 1990 to 2014.
Dr. Hämmerle obtained his doctorate degree from Eberhard Karls Universität Tübingen in 1987 and his undergraduate degree from the University of Hohenheim in 1982.
Aktive Positionen von Hugo Hämmerle
| Unternehmen | Position | Beginn |
|---|---|---|
Tissue Engineering Technologies AG
 Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Gründer | - |
Retina Implant AG
 Retina Implant AG Medical SpecialtiesHealth Technology Retina Implant AG develops sub retinal implants for partially sighted and blind patients. The company was founded in 2003 and is headquartered in Reutlingen, Germany. | Direktor/Vorstandsmitglied | - |
| Eberhard Karls Universität Tübingen | Corporate Officer/Principal | - |
NMI Technologietransfer GmbH
 NMI Technologietransfer GmbH Miscellaneous Commercial ServicesCommercial Services Part of NMI Naturwissenschaftliches & Medizinisches Institut, NMI Technologietransfer GmbH is a contract research organization that consists of three business units: NMI TT Pharmaservices, NMI TT Testing Services, and NMI TT Microdevices. The company is based in Reutlingen, Germany. NMI TT Pharmaservices offers advanced cell-based assays, novel and better cell models, and custom cell lines for the pharma industry, oncology, academia, and cancer research. Additionally, the German company offers electrophysiology services on different target systems such as heart, brain, and retina. The CEO of the company is Hugo Hämmerle. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Hugo Hämmerle
| Unternehmen | Position | Ende |
|---|---|---|
| STRATEC SE | Direktor/Vorstandsmitglied | 18.06.2014 |
Ausbildung von Hugo Hämmerle
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| University of Hohenheim | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| STRATEC SE | Health Technology |
| Private Unternehmen | 3 |
|---|---|
NMI Technologietransfer GmbH
NMI Technologietransfer GmbH Miscellaneous Commercial ServicesCommercial Services Part of NMI Naturwissenschaftliches & Medizinisches Institut, NMI Technologietransfer GmbH is a contract research organization that consists of three business units: NMI TT Pharmaservices, NMI TT Testing Services, and NMI TT Microdevices. The company is based in Reutlingen, Germany. NMI TT Pharmaservices offers advanced cell-based assays, novel and better cell models, and custom cell lines for the pharma industry, oncology, academia, and cancer research. Additionally, the German company offers electrophysiology services on different target systems such as heart, brain, and retina. The CEO of the company is Hugo Hämmerle. | Commercial Services |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Health Technology |
Retina Implant AG
Retina Implant AG Medical SpecialtiesHealth Technology Retina Implant AG develops sub retinal implants for partially sighted and blind patients. The company was founded in 2003 and is headquartered in Reutlingen, Germany. | Health Technology |
